Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.

Journal of vascular and interventional radiology : JVIR - 1 Aug 2015

Lahti Steven J, Xing Minzhi, Zhang Di, Lee James J, Magnetta Michael J, Kim Hyun S

Abstract excerpt

PURPOSE: To evaluate Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status as a prognostic factor for survival after yttrium-90 ((90)Y) radioembolization for colorectal cancer (CRC) liver metastases. MATERIALS AND METHODS: Consecutive patients with unresectable CRC liver metastases and documented KRAS mutation status who were treated with (90)Y radioembolization during the period 2007-2014 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Distribution
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Neoplasms

Share to Pennsylvania

Share to Proportional Hazards Models

Share to Radiopharmaceuticals

Share to Sex Distribution

Share to Survival Analysis

Source

Identifiers

PMID: 26210240
DOI: 10.1016/j.jvir.2015.05.032

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.PMID 26210240Read ↗

Connecting cancer biology and clinical outcomes to imaging in KRAS mutant and wild-type colorectal cancer liver tumors following selective internal radiation therapy with yttrium-90.Semantic proximity Read ↗

Impact of Genomic Mutation and Timing of Y90 Radioembolization in Colorectal Liver Metastases.Semantic proximity Read ↗

Clinical impact of KRAS mutation status on recurrence patterns and the efficacy of local therapy after hepatectomy for colorectal liver metastasesSemantic proximity Read ↗

Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.Semantic proximity Read ↗

KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases.Semantic proximity Read ↗

Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases.Semantic proximity Read ↗

Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.Semantic proximity Read ↗

Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.Semantic proximity Read ↗

Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.Semantic proximity Read ↗

From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis.Semantic proximity Read ↗

BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.